lextemy
mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Æxlishemjandi lyf - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
dymista nefúði, dreifa 137 míkróg / 50 míkróg/skammt
viatris aps - azelastinum hýdróklóríð; fluticasonum própíónat - nefúði, dreifa - 137 míkróg / 50 míkróg/skammt
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg
atomoxetin actavis hart hylki 10 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 10 mg
atomoxetin actavis hart hylki 18 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 18 mg
atomoxetin actavis hart hylki 25 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 25 mg
atomoxetin actavis hart hylki 40 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 40 mg
atomoxetin actavis hart hylki 60 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 60 mg
atomoxetin actavis hart hylki 80 mg
actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 80 mg
myodine vet (nandrodine vet) stungulyf, lausn 25 mg/ml
le vet beheer b.v. - nandrolone laurate - stungulyf, lausn - 25 mg/ml